Literature DB >> 16443041

Kidney stones: pathophysiology and medical management.

Orson W Moe1.   

Abstract

The formation of stones in the urinary tract stems from a wide range of underlying disorders. That clinicians look for the underlying causes for nephrolithiasis is imperative to direct management. There are many advances in genetics, pathophysiology, diagnostic imaging, medical treatment, medical prevention, and surgical intervention of nephrolithiasis. Here, I provide a brief general background and focus mainly on pathophysiology and medical treatment of kidney stones. Although important advances have been made in understanding nephrolithiasis from single gene defects, the understanding of polygenetic causes of kidney stones is still largely elusive. A substantial proportion of data that resulted in new methods of treatment and prevention, which can be empirical or definitive, has focused on urinary luminal chemical composition of the precipitating solutes. Manipulation of inhibitors and epithelial factors is important and needs further investigation. Advances in the management of nephrolithiasis depend on combined efforts of clinicians and scientists to understand the pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443041     DOI: 10.1016/S0140-6736(06)68071-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  218 in total

1.  SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion.

Authors:  Tao Zeng; Xiaolu Duan; Wei Zhu; Yang Liu; Wenqi Wu; Guohua Zeng
Journal:  Urolithiasis       Date:  2017-08-03       Impact factor: 3.436

2.  Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasis.

Authors:  Stephanie K Venn-Watson; Forrest I Townsend; Risa L Daniels; Jay C Sweeney; Jim W McBain; Leigh J Klatsky; Christie L Hicks; Lydia A Staggs; Teri K Rowles; Lori H Schwacke; Randall S Wells; Cynthia R Smith
Journal:  Comp Med       Date:  2010-04       Impact factor: 0.982

3.  Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Authors:  Yun-Sok Ha; Dong-Un Tchey; Ho Won Kang; Yong-June Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim
Journal:  Korean J Urol       Date:  2010-01-21

Review 4.  Management of kidney stones.

Authors:  Nicole L Miller; James E Lingeman
Journal:  BMJ       Date:  2007-03-03

5.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

6.  Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.

Authors:  Jianfu Zhou; Jing Jin; Xiong Li; Zhongxiang Zhao; Lei Zhang; Qian Wang; Jing Li; Qiuhong Zhang; Songtao Xiang
Journal:  Urolithiasis       Date:  2017-05-31       Impact factor: 3.436

7.  Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden.

Authors:  Kirsten Kusumi; Brian Becknell; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

8.  Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.

Authors:  Piyaratana Tosukhowong; Chatchai Yachantha; Thosaphol Sasivongsbhakdi; Supoj Ratchanon; Suchada Chaisawasdi; Chanchai Boonla; Kriang Tungsanga
Journal:  Urol Res       Date:  2008-06-17

9.  Involvement of VKORC1 in the inhibition of calcium oxalate crystal formation in HK-2 cells.

Authors:  Bo Hu; Hao-Ran Wu; Zhi-Yong Ma; Zhuan-Chang Wu; Ying-Mei Lu; Guo-Wei Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

10.  Loss of function dysbiosis associated with antibiotics and high fat, high sugar diet.

Authors:  Aaron W Miller; Teri Orr; Denise Dearing; Manoj Monga
Journal:  ISME J       Date:  2019-01-30       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.